Fate Therapeutics(FATE)
$1.28-0.06 (-4.48%)
FATE
Fate Therapeutics earnings date
$1.28
At close:-0.06 (-4.48%)
Want to see FATE full AI Analyst Report?
Fate Therapeutics (FATE) Q2 2023 Earnings Report
1,295 Followers
FATE Q2 2023 EPS Results
- Actual EPS
- -$0.54
- Consensus EPS
- -$0.59
- Beat/Miss
- Beat by +$0.05
- One Year Ago EPS
- -$0.79
FATE Q2 2023 Revenue Results
- Actual Revenue
- $933.00K
- Expected Revenue
- $5.41M
- Beat/Miss
- Missed by -$4.48M
- YoY Revenue Growth
- -94.97%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/08/2023
- Time
- After Close
- Conference Call
- Tuesday, August 8, 2023
FATE Upcoming Earnings
Fate Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
FATE Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
FATE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.26- | -0.27 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.27-0.25 | -0.27 | 7.41% (+0.02) | |
| Aug 13, 2026 | 2026 (Q2) | -0.27-0.25 | -0.29 | 13.79% (+0.04) | |
| May 13, 2026 | 2026 (Q1) | -0.28-0.26 | -0.32 | 18.75% (+0.06) | |
| Feb 26, 2026 | 2025 (Q4) | -0.27-0.27 | -0.44 | 38.64% (+0.17) | |
| Nov 13, 2025 | 2025 (Q3) | -0.29-0.27 | -0.4 | 32.50% (+0.13) | |
| Aug 12, 2025 | 2025 (Q2) | -0.35-0.29 | -0.33 | 12.12% (+0.04) | |
| May 13, 2025 | 2025 (Q1) | -0.38-0.32 | -0.47 | 31.91% (+0.15) | |
| Mar 05, 2025 | 2024 (Q4) | -0.43-0.44 | -0.45 | 2.22% (+0.01) | |
| Nov 12, 2024 | 2024 (Q3) | -0.42-0.40 | -0.46 | 13.04% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
